Reckitt Benckiser stock gets target price lift as investors weigh softer first-half 2026 results
Published on 08/26/2026 at 19:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Reckitt Benckiser Group (ISIN GB00B24CGK77) stock was quoted at 5,173 GBX on Cboe Europe in real-time estimates on August 26, 2026, leaving the shares up 3.55% since the start of the year but still 17.29% below their level at the beginning of 2026. Recent market data show a last official London close of 5,150 GBX, corresponding to a market capitalization of GBP 32.687 billion as of August 25, 2026. For investors, the latest broker target hike and the company’s softer first-half earnings now frame the debate on valuation and growth.
Analyst target hike highlights valuation debate
On August 26, 2026, an analyst team raised its price target on Reckitt Benckiser stock by 3% to 6,100 pence, while keeping a buy recommendation in place. A broker ratings summary notes that the new 6,100 pence target replaces a previous 5,900 pence objective, implying potential upside of 18.4% against the 5,150 GBX latest closing price in London. Market data compiled on August 26, 2026 point to a consensus average target of 6,223 pence, indicating that the fresh move is slightly below the broader street average.
The updated target is underpinned by expectations for a higher 12-month forward price-to-earnings multiple as earnings grow. A detailed valuation overview shows the revised target corresponding to a projected 12-month P/E of 16.5 times for 2026, compared with a current consensus near 14.5 times. The same overview shows the shares trading at 5,173 GBX in intraday estimates on August 26, 2026, versus the prior close of 5,150 GBX, which keeps the stock at a discount to the average target by 20.84%.
For investors, the core question is whether the stock’s discount to target prices can be sustained if margins stabilize and organic growth holds up, or whether recent fundamental pressures justify the current lower multiple. The analyst commentary embedded in the valuation overview stresses that like-for-like revenue growth above 6% in the second quarter of 2026 is being set against weaker regional margins and negative price/mix effects, which is shaping a more nuanced view of the shares.
First-half 2026 results show pressure on revenue and profit
Reckitt Benckiser’s latest reported numbers cover the first half of 2026 and the second quarter of 2026, giving a clear snapshot of how the business is performing this year. According to an earnings roundup published on August 26, 2026, the group generated net revenue of GBP 6.411 billion in the first half of 2026, down from GBP 6.981 billion in the same period a year earlier, a year-over-year decline of 8.2%. The same compilation reports operating profit for the half-year of GBP 1.166 billion versus GBP 1.498 billion in the first half of the prior year, a drop of 22.2%.
The decline in profit was also visible at the bottom line. In the first half of 2026, net profit attributable to equity holders came in at GBP 652 million, compared with GBP 958 million a year earlier, representing a 31.9% decrease. In the second quarter alone, group revenue reached GBP 3.166 billion, with the Core Reckitt franchise contributing GBP 2.512 billion, equivalent to USD 3.43 billion at the exchange rate cited in the same report. These figures confirm that while sales remain substantial, profitability has been squeezed compared with the prior year period.
Regional dynamics form a key part of this story. Commentary accompanying the target-hike analysis highlights that the price/mix effect remained negative in the first half of 2026 in both North America and Europe. That assessment notes that operating margins in North America and Europe declined by more than 250 basis points year-on-year in the first half of 2026. Analysts expect like-for-like organic growth in these two regions to moderate to about 4.5% by the fourth quarter of 2026, down from more than 6% in the second quarter, as pricing and volumes normalize.
The combination of strong organic growth and weaker margins explains much of the push and pull around the shares. On one hand, more than 6% like-for-like growth in the second quarter of 2026 in key categories suggests resilient demand for branded household and personal care products. On the other, a margin compression of over 250 basis points in major developed markets exerts pressure on earnings per share, prompting analysts in the same report to trim their profit estimates for fiscal 2026 and 2027 by about 1%. The modest downgrade indicates that the profit outlook is softening but not collapsing, which supports the idea of a re-rating only if management can reverse the margin trend.
Consensus view and relative performance
Market data assembled on August 26, 2026 show Reckitt Benckiser stock at 5,169 GBX on a real-time Cboe Europe snapshot, representing a 0.45% gain on the day and a 3.08% advance since January 1, 2026. The same consensus page places the last official close at 5,150 GBX and confirms that, despite the modest year-to-date gain, the stock remains more than 14% below its level at the start of 2026 in the Cboe Europe context, consistent with the larger 17.29% decline versus the beginning of the year on another regional feed.
The consensus table also points to a moderate recovery expected in revenue and net income over the next financial years, with analysts modeling higher net sales and earnings compared with the recent historical figures listed through 2025. While these forward-looking figures are projections rather than reported results, they illustrate why the stock still commands buy ratings from several houses and why an uplift in the target price can coexist with evidence of near-term margin pressure. Investors comparing the 20.84% gap between the 5,150 GBX close and the 6,223 pence average target may see scope for upside if the company executes on its cost and pricing strategies.
Relative to a peer group of large European consumer goods and personal products companies, the updated 12-month forward P/E ratio of 16.5 times described in the valuation commentary places Reckitt Benckiser at a discount to some faster-growing beauty names but broadly in line with diversified household-product makers. The key differentiator is the trajectory of like-for-like growth: maintaining organic growth above 4.5% in North America and Europe into late 2026, as expected by the analysts cited, would make the current valuation look more attractive compared with companies with weaker top-line momentum but higher margins.
Flagship hygiene and health brands remain central
Beyond the short-term market reaction, Reckitt Benckiser’s investment case continues to rest on its portfolio of well-known hygiene, health and nutrition brands. Products such as Dettol surface disinfectants and antibacterial soaps, as well as the Lysol and Finish lines in various markets, form the backbone of its hygiene segment and have historically benefited from consumer focus on cleanliness. The company’s health portfolio, which includes over-the-counter remedies and wellness products, and its nutrition offerings in infant formula and supplements, provide additional scale and geographic diversification.
In the first half of 2026, the Core Reckitt business unit generated revenue of GBP 2.512 billion in the second quarter alone, underscoring the importance of these leading brands to the overall group. The earnings recap from August 26, 2026 shows that Core Reckitt’s USD 3.43 billion equivalent in second-quarter sales represented a substantial share of total group revenue of GBP 3.166 billion in that period. For long-term holders, the performance of these flagship brands, their pricing power, and their ability to sustain or grow market share will be central factors in whether the company can rebuild margins while keeping organic growth in mid-single digits.
Reckitt Benckiser stock and current trading snapshot
As of the latest completed London session on August 25, 2026, Reckitt Benckiser stock closed at 5,150 GBX on the London Stock Exchange, while intraday indications on August 26, 2026 show trading closer to 5,173 GBX on Cboe Europe. This combined trading and valuation snapshot highlights that, despite the modest year-to-date gain of 3.55%, the shares still sit well below their level at the start of 2026 and trade at a material discount to both the new 6,100 pence target and the 6,223 pence consensus average.
For investors, the current setup balances several quantifiable factors. First, the first half of 2026 saw net revenue decline by 8.2% and net profit drop by 31.9% versus the prior year, with operating profit falling 22.2%, underscoring the pressure from costs and pricing in key regions. Second, organic growth above 6% in the second quarter and expectations for like-for-like growth of about 4.5% in North America and Europe by the fourth quarter suggest that demand remains healthy even as margins compress. Third, the valuation overlay, with a discount of more than 20% against the average target and a 12-month forward P/E stepping up to 16.5 times from a current consensus 14.5 times, indicates that the market is still cautious but could re-rate the stock if profitability stabilizes.
Read more
More on Reckitt Benckiser stock in the company investor area
Hygiene brands anchor the consumer proposition
Reckitt Benckiser’s hygiene division, which includes Dettol-branded disinfectants and cleaning products, remains one of the company’s most recognizable pillars. Dettol household cleaners and personal hygiene items offer antibacterial protection across multiple formats, from sprays and wipes to hand washes, and they have long served as a key driver of awareness for the broader group. With Core Reckitt delivering GBP 2.512 billion of revenue in the second quarter of 2026, the continued strength of hygiene brands like Dettol will play a significant role in whether the company can sustain the more than 6% like-for-like growth reported for that quarter while working to rebuild margins.
Stock positioning in a shifting consumer landscape
Reckitt Benckiser stock currently reflects a mix of cautious sentiment and latent optimism. On the one hand, the shares’ position 17.29% below their level at the start of 2026 and the decline in first-half net revenue to GBP 6.411 billion and net profit to GBP 652 million signal that investors have already priced in meaningful earnings pressure. On the other, the new 6,100 pence target, which is 18.4% above the 5,150 GBX latest close and backed by expectations for a 12-month forward P/E of 16.5 times versus today’s 14.5 times, shows that some analysts see scope for re-rating if the company can deliver on efficiency measures and stabilize margins in North America and Europe.
Fact box
Company: Reckitt Benckiser Group plc
ISIN: GB00B24CGK77
Ticker: RKT
Exchange: London Stock Exchange
Price (as of August 25, 2026, London close): 5,150 GBX
Market cap: GBP 32.687 billion (as of August 25, 2026)
Sector / Industry: Household and personal products
Index membership: FTSE 100
